PL1853296T3 - Zastosowanie cyklicznego undekapeptydu do wytwarzania leku do podawania w trakcie zdarzeń niedokrwienia mięśnia sercowego - Google Patents

Zastosowanie cyklicznego undekapeptydu do wytwarzania leku do podawania w trakcie zdarzeń niedokrwienia mięśnia sercowego

Info

Publication number
PL1853296T3
PL1853296T3 PL06704161T PL06704161T PL1853296T3 PL 1853296 T3 PL1853296 T3 PL 1853296T3 PL 06704161 T PL06704161 T PL 06704161T PL 06704161 T PL06704161 T PL 06704161T PL 1853296 T3 PL1853296 T3 PL 1853296T3
Authority
PL
Poland
Prior art keywords
medicament
preparation
administration during
during myocardial
cyclic undecapeptide
Prior art date
Application number
PL06704161T
Other languages
English (en)
Inventor
Pietro Scalfaro
Jean-Maurice Dumont
Grégoire Vuagniaux
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Publication of PL1853296T3 publication Critical patent/PL1853296T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06704161T 2005-01-10 2006-01-10 Zastosowanie cyklicznego undekapeptydu do wytwarzania leku do podawania w trakcie zdarzeń niedokrwienia mięśnia sercowego PL1853296T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05000357 2005-01-10
PCT/EP2006/050140 WO2006072639A1 (fr) 2005-01-10 2006-01-10 Utilisation d’un undecapeptide cyclique pour la preparation d’un médicament administrable lors de situations ischemiques myocardiques
EP06704161A EP1853296B1 (fr) 2005-01-10 2006-01-10 Utilisation d'un undécapeptide cyclique pour la préparation d'un médicament administrable lors de situations ischémiques myocardiaques

Publications (1)

Publication Number Publication Date
PL1853296T3 true PL1853296T3 (pl) 2012-12-31

Family

ID=34933239

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06704161T PL1853296T3 (pl) 2005-01-10 2006-01-10 Zastosowanie cyklicznego undekapeptydu do wytwarzania leku do podawania w trakcie zdarzeń niedokrwienia mięśnia sercowego

Country Status (9)

Country Link
US (1) US8889629B2 (pl)
EP (1) EP1853296B1 (pl)
JP (1) JP2008526816A (pl)
DK (1) DK1853296T5 (pl)
ES (1) ES2387682T3 (pl)
PL (1) PL1853296T3 (pl)
PT (1) PT1853296E (pl)
SI (1) SI1853296T1 (pl)
WO (1) WO2006072639A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2023948A1 (en) * 2006-05-04 2009-02-18 Michel Ovize Use of cyclosporin a or melle4-cyclosporin for the treatment of acute myocardial infarction
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
WO2011141891A1 (en) 2010-05-12 2011-11-17 Debio Recherche Pharmaceutique S.A. Use of cycloundecadepsipeptide compounds
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
WO2014150388A1 (en) * 2013-03-15 2014-09-25 Boston Scientific Scimed, Inc. System for controlling a tissue-stapling operation with pressurized fluid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2306448A1 (en) * 1997-10-16 1999-04-22 Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with nf-at3 function
SK12342000A3 (sk) * 1998-02-27 2001-03-12 Pfizer Products Inc. Deriváty n-[(substituovaný päťčlenný di-alebo triáza-di- -nenasýtený kruh)karbonyl] guanidínu pre liečenie ischémie
CN1218958C (zh) 1998-07-01 2005-09-14 德比奥药物股份有限公司 活性范围改善的环孢菌素
US6790935B1 (en) * 1999-02-05 2004-09-14 Debiopharm S.A. Cyclosporin derivatives and method for the production of said derivatives

Also Published As

Publication number Publication date
US8889629B2 (en) 2014-11-18
WO2006072639A1 (fr) 2006-07-13
DK1853296T5 (da) 2013-03-18
SI1853296T1 (sl) 2012-10-30
JP2008526816A (ja) 2008-07-24
DK1853296T3 (da) 2012-09-03
EP1853296A1 (fr) 2007-11-14
ES2387682T3 (es) 2012-09-28
EP1853296B1 (fr) 2012-06-20
PT1853296E (pt) 2012-09-26
US20090023640A1 (en) 2009-01-22

Similar Documents

Publication Publication Date Title
IL187461A (en) Use of a 1-dioxinogirimycin derivative for the preparation of a single therapy drug for the treatment of pomp disease
IL181304A (en) Use of dihydroprididone for the preparation of a drug for the treatment of spinal cord dysplasia
EP1757273A4 (en) PREPARATION FOR ORAL ADMINISTRATION
HK1107672A1 (en) Conveniently implantable sustained release drug compositions
IL178302A (en) Use of Natalizumab in the preparation of a drug to reduce the need for steroid therapy
IL206789A (en) A converted cyclic amide compound, a pharmaceutical preparation containing the compound and the use of a compound or pharmaceutical preparation in a pharmaceutical preparation
ZA200704163B (en) Oral medicament for the modified release of at least one active principle, in a multimicrocapsule form
HK1127877A1 (en) Composition containing peptide as the active ingredient
TWI366457B (en) Use of a beta2-adrenoceptor agonist for the preparation of a dermatological medicament
GB0524958D0 (en) Transdermal administration of active agents
EP2100609A4 (en) MEDICAL PREPARATION IN SOLID FORM CONTAINING MANNITOL OR LACTOSE
IL183929A0 (en) Use of inerferon - ?? in the preparation of a medicament
EP2260851A4 (en) USE OF PENTACYCLIC TRITERPEN FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND FOR THE TREATMENT OF MULTIPLE SCLEROSIS
WO2012056402A3 (en) Formulations and methods for attenuating respiratory depression induced by opioid overdose
EP1729786A4 (en) ADMINISTRATION OF CISPLATIN BY INHALATION
IL181827A0 (en) Donepezil salts suitable for the preparation of pharmaceutical compositions
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
PL1853296T3 (pl) Zastosowanie cyklicznego undekapeptydu do wytwarzania leku do podawania w trakcie zdarzeń niedokrwienia mięśnia sercowego
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases
IL183930A0 (en) Use of cladribine for preparation of pharmaceutical compositions
PL1858496T3 (pl) Poprzezskórny układ terapeutyczny do aplikowania środków przeciwbólowych
IL181819A (en) Use of Benzo-compound compounds for the preparation of pharmaceuticals and the uses of these @ compounds
GB0402492D0 (en) Pharmaceutically active compounds
PL2379066T3 (pl) Zastosowanie antagonistów opioidów do otrzymywania leku w leczeniu chorób zwyrodnieniowych siatkówki